William Callahan
Direktor/Vorstandsmitglied bei MEDISUN PRECISION MEDICINE LTD.
Aktive Positionen von William Callahan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MEDISUN PRECISION MEDICINE LTD. | Direktor/Vorstandsmitglied | 01.07.2015 | - |
| Independent Dir/Board Member | 01.07.2015 | - |
Karriereverlauf von William Callahan
Ehemalige bekannte Positionen von William Callahan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Geschäftsführer | 19.11.2009 | 01.02.2012 |
| TALPHERA, INC. | Corporate Officer/Principal | 01.03.2014 | - |
Ausbildung von William Callahan
| San Francisco State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TALPHERA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Medisun Precision Medicine Ltd.
 Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |
- Börse
- Insiders
- William Callahan
- Erfahrung